ÂÜÀòÂÒÂ×

Katia Melnik is a seasoned professional in Regulatory Affairs, with a strong background in Chemistry, Manufacturing, and Controls (CMC). Currently serving as RA CMC Senior Manager at Covis Pharma since August 2021, Katia previously held roles of RA CMC Expert and Regulatory Compliance Specialist at Galderma from June 2018 to June 2021 and November 2014 to May 2018, respectively. Early in their career, Katia contributed as a Regulatory Affairs Associate at Sandoz Canada Inc. and Lek Pharmaceuticals, and as a Quality Assurance - Validation Technician at Johnson & Johnson in Canada. Katia's education includes a Master's degree in Pharmaceutical Sciences - Drug Development and a Post-Graduate Degree in Drug Development from Université de Montréal, along with a degree from Universidade Federal do Paraná.